Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study
about
sameAs
Learning on the Web. Case 2: patent foramen ovale (PFO) and paradoxical embolismTranscranial Doppler ultrasonography: From methodology to major clinical applications.Embolic Strokes of Unknown Source and Cryptogenic Stroke: Implications in Clinical PracticePatent Foramen Ovale and Stroke-Current StatusPatent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trialsPatent foramen ovale closure and medical treatments for secondary stroke prevention: a systematic review of observational and randomized evidencePrevention of recurrent stroke in patients with patent foramen ovaleIndications for the closure of patent foramen ovaleAtrial septal abnormalities and cryptogenic stroke: a paradoxical scienceImpact of valvular thickness on stroke recurrence in medically treated patients with strokeCardioembolic Stroke.Practice advisory: Recurrent stroke with patent foramen ovale (update of practice parameter): Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of NeurologyAntithrombotic and interventional treatment options in cardioembolic transient ischaemic attack and ischaemic stroke.Transesophageal echocardiography in patients with cryptogenic cerebral ischemia.Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant data meta-analysis.Patent foramen ovale closure: past, present and future.Transcranial Doppler ultrasonography should it be the first choice for persistent foramen ovale screening?Contemporary approach to paradoxical embolism.The risk of paradoxical embolism (RoPE) study: initial description of the completed databaseDecrease in shunt volume in patients with cryptogenic stroke and patent foramen ovale.Aortic arch plaques and risk of recurrent stroke and deathNon-cardioembolic Mechanisms in Cryptogenic Stroke: Clinical and Diffusion-weighted Imaging Features.Investigation of association between PFO complicated by cryptogenic stroke and a common variant of the cardiac transcription factor GATA4.Recurrent stroke predictors differ in medically treated patients with pathogenic vs. other PFOsPercutaneous closure versus medical therapy alone for cryptogenic stroke patients with a patent foramen ovale: meta-analysis of randomized controlled trials.Antithrombotic therapy in cardiac embolism.Determinants of antithrombotic choice for patent foramen ovale in cryptogenic stroke.Caring for the adult with congenital heart disease: management of common defectsCryptogenic stroke: time to determine aetiology.Cryptogenic stroke following abdominal free flap breast reconstruction surgeryTranscatheter patent foramen ovale closure versus medical therapy for cryptogenic stroke: a meta-analysis of randomized clinical trials.Antithrombotic medication for cardioembolic stroke preventionIntermediate and long-term results of transcatheter closure of patent foramen ovale using the amplatzer patent foramen ovale occluder: one case of pulmonary embolism irrespective of patent foramen ovale closure.The Risk of Paradoxical Embolism (RoPE) Study: developing risk models for application to ongoing randomized trials of percutaneous patent foramen ovale closure for cryptogenic stroke.Antiplatelet therapy in secondary stroke prevention--state of the artAmyloid mediates the association of apolipoprotein E e4 allele to cognitive function in older peopleIndication and techniques of transcatheter closure of patent foramen ovale.Prevention of cardioembolic stroke.Short-Term and Two-Year Rate of Recurrent Cerebrovascular Events in Patients with Acute Cerebral Ischemia of Undetermined Aetiology, with and without a Patent Foramen OvaleAntithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
P2860
Q24673936-46F6AB20-4B6E-4155-91A0-2214EFD3F944Q26741104-534C1D20-0734-4588-AA1E-36CCD62EDD89Q26752352-EF523250-43F9-46D9-82A6-FACC85B6CD13Q26781929-6410D099-568D-4DB5-9E73-BB77D0C02812Q26829540-2828337C-E04D-4B80-BD7C-5354C409EB0BQ26851838-3C1A1F82-CF52-4D9A-AC2B-873C7818F583Q27007029-2B788DB7-2C4C-440D-98D4-D7DB0050D2E0Q28166833-A8F06F25-12EA-4403-9D70-C0C29037CE5BQ28174489-3B9F3427-9800-4BDD-A9FB-16CAB4A84080Q28221124-1A9C5921-0AA3-4426-B944-FAD27F1A5596Q30238631-0F9EBE32-A2AF-40A2-B183-B514937452BEQ30248752-AEC9383E-0385-4B07-970E-60E0F9A18538Q30484358-28D10388-5D6E-44CB-BF97-902F9E6ECB87Q30486966-28D7BF25-FAA3-4565-89CB-D47E9A310E3FQ30978475-3FE391B1-262F-4B78-8471-C2B62FF17739Q33298975-FB517FF5-48B4-4142-B941-578C9F7C4845Q33713170-5559B97E-D0F2-495C-9D2E-B6CD57B74241Q33741560-7CA64665-43CE-44CF-BB01-2605404B617DQ33768313-DB8C8C8E-0297-4EB6-998E-304D27E820A3Q33781690-275D3B60-529F-45C7-9932-B09D1112DBEFQ33787441-C9E5F59B-E3BD-4724-8ECF-8C62F16768BAQ33790681-7EBB333A-5026-45EE-9606-F9D8B9F03121Q33932840-5131D07D-FDFA-42FF-9DA7-7265B25DDE27Q33981271-56BFD019-40DE-4637-8C3F-051DFD74DC64Q33996768-CF0270B6-D7FA-458E-BD5B-071E4A3FB377Q34362901-A4C3D6BC-FEB6-40DF-92B5-FA1589636667Q34591244-A3492D8D-EEFF-4A50-85B8-7792AF720AC0Q34675406-3E58B16F-61E4-4159-A5D7-509C09FFF204Q34738763-707036B2-1B42-4EDB-BF1A-282E6E3FBE04Q34768461-0B583F1E-B6C3-49D7-A2EB-7F01666F1B0EQ35065078-BB4E4FDC-02D4-49AE-92D2-3A144F93D8B7Q35142419-9A676C3E-5D15-439F-AE2E-56B7C0CC27CBQ35154437-64F7D24E-CE8C-4E2D-828C-82FCD806ECABQ35206129-8A1F906A-BD70-4B35-844B-007D9E3A68A5Q35216412-C2FF1C5D-9B31-4CCA-BF7D-5F2E8D63B6C3Q35490069-13DB85E4-CF1C-4F8C-852A-645464F34D06Q35591202-DA51920A-DF2D-455A-A974-B1EEEA7A30F1Q35648111-B6AFF5CB-4CB6-425E-B481-4A637EF4BB5BQ35687226-D3C236B2-1A0B-47A0-8483-5F37F8E418BDQ35752576-7D4C5DEA-AAA8-40C3-A523-84BF14FDA430
P2860
Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Effect of medical treatment in ...... le in Cryptogenic Stroke Study
@ast
Effect of medical treatment in ...... le in Cryptogenic Stroke Study
@en
Effect of medical treatment in ...... le in Cryptogenic Stroke Study
@nl
type
label
Effect of medical treatment in ...... le in Cryptogenic Stroke Study
@ast
Effect of medical treatment in ...... le in Cryptogenic Stroke Study
@en
Effect of medical treatment in ...... le in Cryptogenic Stroke Study
@nl
prefLabel
Effect of medical treatment in ...... le in Cryptogenic Stroke Study
@ast
Effect of medical treatment in ...... le in Cryptogenic Stroke Study
@en
Effect of medical treatment in ...... le in Cryptogenic Stroke Study
@nl
P2093
P3181
P1433
P1476
Effect of medical treatment in ...... le in Cryptogenic Stroke Study
@en
P2093
Marco R Di Tullio
Robert R Sciacca
Shunichi Homma
P304
P3181
P356
10.1161/01.CIR.0000017498.88393.44
P407
P577
2002-06-04T00:00:00Z